The FDA today announced a series of upper-level personnel changes coming hot on the heels of last week's appointment of Lester Crawford as permanent commissioner.
*Steven Galson has been tapped to lead the agency's Center for Drug Evaluation and Research (CDER). Galson joined FDA in 2001 as the deputy director of CDER and most recently served in the role of acting director.
*Janet Woodcock will become deputy commissioner for operations and chief operating officer on a permanent basis following her experience in this position as acting deputy commissioner. Woodcock was previously director of CDER.
*Scott Gottlieb, a former FDA and Centers for Medicare and Medicaid Services senior official, will return to the agency as deputy commissioner for medical and scientific Affairs.
*Murray Lumpkin will become deputy commissioner for international and special programs, also on a permanent basis, following his acting duties in the same position.
*Patrick Ronan, currently associate commissioner for legislation, will become chief staff officer to Crawford. Ronan will serve as the principal liaison to Department of Health and Human Services.